Related references
Note: Only part of the references are listed.Inhibition of kras-derived exosomes downregulates immunosuppressive BACH2/GATA-3 expression via RIP-3 dependent necroptosis and miR-146/miR-210 modulation
Savvas Petanidis et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Saikosaponin A Inhibits Triple-Negative Breast Cancer Growth and Metastasis Through Downregulation of CXCR4
Ying Wang et al.
FRONTIERS IN ONCOLOGY (2020)
CircFADS2: A potential prognostic biomarker of colorectal cancer
Yi-Sheng Xiao et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2020)
Reduced Expression ofMETTL3Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-MediatedCOL3A1Up-Regulation
Yu Shi et al.
FRONTIERS IN ONCOLOGY (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
The inhibitive effect of sh-HIF1A-AS2 on the proliferation, invasion, and pathological damage of breast cancer via targeting miR-548c-3p through regulating HIF-1 alpha/VEGF pathway in vitro and vivo
Xiao Guo et al.
ONCOTARGETS AND THERAPY (2019)
circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis
Jian-Zhen Xu et al.
CELL DEATH & DISEASE (2019)
Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression
Xiaoyan Cai et al.
CELL DEATH & DISEASE (2019)
Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
Anna Wawruszak et al.
CANCERS (2019)
Targeting the circBMPR2/miR-553/USP4 Axis as a Potent Therapeutic Approach for Breast Cancer
Yiran Liang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer
Yiran Liang et al.
ONCOGENE (2019)
N6-Methyladenosine Modification Controls Circular RNA Immunity
Y. Grace Chen et al.
MOLECULAR CELL (2019)
CircRNA-UCK2 increased TET1 inhibits proliferation and invasion of prostate cancer cells via sponge miRNA-767-5p
Zhendong Xiang et al.
OPEN MEDICINE (2019)
Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial
Dhivya R. Sudhan et al.
CLINICAL CANCER RESEARCH (2019)
miR-186 inhibits proliferation, migration, and epithelial-mesenchymal transition in breast cancer cells by targeting Twist1
Wen-juan Sun et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
CircRNA hsa_circRNA_101996 increases cervical cancer proliferation and invasion through activating TPX2 expression by restraining miR-8075
Tiefang Song et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway
Liang Xia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Metastatic and triple-negative breast cancer: challenges and treatment options
Sumayah Al-Mahmood et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)
The pro-metastasis effect of circANKS1B in breast cancer
Kaixuan Zeng et al.
MOLECULAR CANCER (2018)
circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a
Rongfang He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer
Lingshuang Lu et al.
ONCOTARGET (2017)
Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma
Meilin Qin et al.
CANCER BIOMARKERS (2016)
The transcription factor BACH2 promotes tumor immunosuppression
Rahul Roychoudhuri et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
CXCR4-Targeted Nanocarriers for Triple Negative Breast Cancers
Asish C. Misra et al.
BIOMACROMOLECULES (2015)
CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
Jingyu Xiang et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed
Agnieszka Rybak-Wolf et al.
MOLECULAR CELL (2015)
Treatment of triple negative breast cancer (TNBC): current options and future perspectives
M. De Laurentiis et al.
CANCER TREATMENT REVIEWS (2010)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer (vol 155, pg 231, 2009)
Eugene H. Huang et al.
JOURNAL OF SURGICAL RESEARCH (2010)
A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer
Eugene H. Huang et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Functions of CXCL12 and CXCR4 in breast cancer
Kathryn E. Luker et al.
CANCER LETTERS (2006)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
The transcriptional programme of antibody class switching involves the repressor Bach2
A Muto et al.
NATURE (2004)
Share Paper
